These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1810811)

  • 1. The long-term treatment with the Ca(2+)-antagonists nifedipine, verapamil, flunarizine and with the calmodulin antagonist trifluoperazine decreases the activity of 5-HT1 receptors in rat cerebral cortex and hippocampus.
    Popova J; Staneva-Stoytcheva D; Ivanova E; Tosheva T
    Gen Pharmacol; 1991; 22(6):1147-9. PubMed ID: 1810811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in benzodiazepine receptors of rat brain after long-term treatment with the Ca(2+)-antagonists nifedipine, verapamil, flunarizine and with the calmodulin antagonist trifluoperazine.
    Staneva-Stoytcheva D; Danchev N; Popov P
    Gen Pharmacol; 1991; 22(6):1151-4. PubMed ID: 1667304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the Ca2(+)-antagonists nifedipine, verapamil, flunarizine and of the calmodulin antagonist trifluoperazine on muscarinic cholinergic receptors in rat cerebral cortex.
    Popova J; Staneva-Stoytcheva D; Mutafova V
    Gen Pharmacol; 1990; 21(3):317-9. PubMed ID: 2341018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of long-term treatment with the Ca2(+)-antagonists nifedipine, verapamil, flunarizine and with the calmodulin antagonist trifluoperazine on beta-adrenoceptors in rat cerebral cortex.
    Staneva-Stoytcheva D; Popova J; Mutafova-Yambolieva V; Alov P
    Gen Pharmacol; 1990; 21(1):149-52. PubMed ID: 2153606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term treatment with different calcium- and calmodulin-antagonists induces changes in rat brain alpha-adrenoceptors.
    Staneva-Stoytcheva D; Dantchev N; Popov P
    Gen Pharmacol; 1992 Jan; 23(1):61-3. PubMed ID: 1317312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of L-type calcium channel antagonists on the serotonin-depleting actions of MDMA in rats.
    Finnegan KT; Calder L; Clikeman J; Wei S; Karler R
    Brain Res; 1993 Feb; 603(1):134-8. PubMed ID: 8095837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of nifedipine, verapamil, diltiazem and trifluoperazine on the antinociceptive activity of acetaminophen.
    Koleva M; Dimova S
    Methods Find Exp Clin Pharmacol; 2000 Dec; 22(10):741-5. PubMed ID: 11346895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium channel blockers inhibit the (Ca2+ + Mg2+)-ATPase activity and the 125I-calmodulin binding in brain membranes.
    Santos DL; Lopes MC; Carvalho CM
    Eur J Pharmacol; 1994 May; 267(3):307-16. PubMed ID: 8088369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for down-regulation of 3H-nitrendipine recognition sites in mouse brain after long-term treatment with nifedipine or verapamil.
    Panza G; Grebb JA; Sanna E; Wright AG; Hanbauer I
    Neuropharmacology; 1985 Nov; 24(11):1113-7. PubMed ID: 3001573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of [3H]nitrendipine binding and KCl-induced calcium uptake in rat cortical synaptosomes.
    Wei JW; Chiang DH
    Gen Pharmacol; 1985; 16(3):211-6. PubMed ID: 3160632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of nifedipine, verapamil, diltiazem and trifluoperazine on acetaminophen toxicity in mice.
    Dimova S; Koleva M; Rangelova D; Stoythchev T
    Arch Toxicol; 1995; 70(2):112-8. PubMed ID: 8773183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of calcium antagonists nifedipine and flunarizine on phencyclidine-induced changes in the regional dopaminergic metabolism of the rat brain.
    Etou K; Kuroki T; Tatebayashi Y; Tashiro N; Hirano M
    Biochem Pharmacol; 1996 Jan; 51(1):83-6. PubMed ID: 8534272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of calmodulin antagonists and calcium channel blockers on triiodothyronine uptake by rat hepatoma and myoblast cell lines.
    Topliss DJ; Scholz GH; Kolliniatis E; Barlow JW; Stockigt JR
    Metabolism; 1993 Mar; 42(3):376-80. PubMed ID: 8487658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of verapamil, nifedipine and flunarizine on haemodynamics and regional blood flows in pentobarbitone-anaesthetized rats.
    Waite RP; Pang CC; Walker MJ
    J Pharm Pharmacol; 1990 May; 42(5):325-31. PubMed ID: 1976779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of calcium antagonists on KCl-evoked calcium uptake by rat cortical synaptosomes.
    Wei JW; Chiang DH
    Gen Pharmacol; 1986; 17(3):261-5. PubMed ID: 3721183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The binding of [3H]nitrendipine to receptors for calcium channel antagonists in the heart, cerebral cortex, and ileum of rats.
    Ehlert FJ; Roeske WR; Itoga E; Yamamura HI
    Life Sci; 1982 Jun; 30(25):2191-202. PubMed ID: 7109844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of trifluoperazine, compound 48/80, TMB-8 and verapamil on the rate of calmodulin binding to erythrocyte Ca2+-ATPase.
    Scharff O; Foder B
    Biochim Biophys Acta; 1984 Apr; 772(1):29-36. PubMed ID: 6231956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible role of calcium uptake and calmodulin in adrenal glomerulosa cells: effects of verapamil and trifluoperazine.
    Balla T; Hunyady L; Spät A
    Biochem Pharmacol; 1982 Apr; 31(7):1267-71. PubMed ID: 6284173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium ionophore (A23187)- and arachidonic acid-stimulated prostaglandin release from microvascular endothelial cells: effects of calcium antagonists and calmodulin inhibitors.
    Gerritsen ME; Nganele DM; Rodrigues AM
    J Pharmacol Exp Ther; 1987 Mar; 240(3):837-46. PubMed ID: 3104581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The characteristics of the action of calcium antagonists on glucose transport in the rat small intestine].
    Gurman EG
    Fiziol Zh SSSR Im I M Sechenova; 1990 Apr; 76(4):509-14. PubMed ID: 2170179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.